BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24128935)

  • 1. Impact of TCF7L2 single nucleotide polymorphisms on hydrochlorothiazide-induced diabetes.
    Karnes JH; Gong Y; Pacanowski MA; McDonough CW; Arwood MJ; Langaee TY; Pepine CJ; Johnson JA; Cooper-Dehoff RM
    Pharmacogenet Genomics; 2013 Dec; 23(12):697-705. PubMed ID: 24128935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association of the HMGA1 IVS5-13insC variant with type 2 diabetes in an ethnically diverse hypertensive case control cohort.
    Karnes JH; Langaee TY; McDonough CW; Chang SW; Ramos M; Catlin JR; Casanova OE; Gong Y; Pepine CJ; Johnson JA; Cooper-Dehoff RM
    J Transl Med; 2013 Jan; 11():12. PubMed ID: 23302499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variants of the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in an African-American population enriched for nephropathy.
    Sale MM; Smith SG; Mychaleckyj JC; Keene KL; Langefeld CD; Leak TS; Hicks PJ; Bowden DW; Rich SS; Freedman BI
    Diabetes; 2007 Oct; 56(10):2638-42. PubMed ID: 17601994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resequencing and analysis of variation in the TCF7L2 gene in African Americans suggests that SNP rs7903146 is the causal diabetes susceptibility variant.
    Palmer ND; Hester JM; An SS; Adeyemo A; Rotimi C; Langefeld CD; Freedman BI; Ng MC; Bowden DW
    Diabetes; 2011 Feb; 60(2):662-8. PubMed ID: 20980453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of TCF7L2 gene polymorphisms, methylation, and gene-environment interaction with type 2 diabetes mellitus risk: A nested case-control study in the Rural Chinese Cohort Study.
    Qie R; Han M; Huang S; Li Q; Liu L; Zhang D; Cheng C; Zhao Y; Liu D; Qin P; Guo C; Zhou Q; Tian G; Zhang Y; Wu X; Wu Y; Li Y; Yang X; Zhao Y; Feng Y; Hu F; Zhang M; Hu D; Lu J
    J Diabetes Complications; 2021 Mar; 35(3):107829. PubMed ID: 33419631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrochlorothiazide-induced hyperuricaemia in the pharmacogenomic evaluation of antihypertensive responses study.
    Vandell AG; McDonough CW; Gong Y; Langaee TY; Lucas AM; Chapman AB; Gums JG; Beitelshees AL; Bailey KR; Johnson RJ; Boerwinkle E; Turner ST; Cooper-DeHoff RM; Johnson JA
    J Intern Med; 2014 Nov; 276(5):486-97. PubMed ID: 24612202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population.
    Chandak GR; Janipalli CS; Bhaskar S; Kulkarni SR; Mohankrishna P; Hattersley AT; Frayling TM; Yajnik CS
    Diabetologia; 2007 Jan; 50(1):63-7. PubMed ID: 17093941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation in the beta2 subunit of the voltage-gated calcium channel and pharmacogenetic association with adverse cardiovascular outcomes in the INternational VErapamil SR-Trandolapril STudy GENEtic Substudy (INVEST-GENES).
    Niu Y; Gong Y; Langaee TY; Davis HM; Elewa H; Beitelshees AL; Moss JI; Cooper-Dehoff RM; Pepine CJ; Johnson JA
    Circ Cardiovasc Genet; 2010 Dec; 3(6):548-55. PubMed ID: 21156931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of KCNQ1, CDKN2A/2B, CDKAL1, HHEX, MTNR1B, SLC30A8, TCF7L2, and UBE2E2 on risk of developing type 2 diabetes in Thai population.
    Plengvidhya N; Chanprasert C; Chongjaroen N; Yenchitsomanus PT; Homsanit M; Tangjittipokin W
    BMC Med Genet; 2018 Jun; 19(1):93. PubMed ID: 29871606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver X receptor α gene polymorphisms and variable cardiovascular outcomes in patients treated with antihypertensive therapy: results from the INVEST-GENES study.
    Price ET; Pacanowski MA; Martin MA; Cooper-DeHoff RM; Pepine CJ; Zineh I; Johnson JA
    Pharmacogenet Genomics; 2011 Jun; 21(6):333-40. PubMed ID: 21562465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between TCF7L2 polymorphisms and risk of breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities Study.
    Connor AE; Baumgartner RN; Baumgartner KB; Kerber RA; Pinkston C; John EM; Torres-Mejia G; Hines L; Giuliano A; Wolff RK; Slattery ML
    Breast Cancer Res Treat; 2012 Nov; 136(2):593-602. PubMed ID: 23085767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel TCF7L2 type 2 diabetes SNP identified from fine mapping in African American women.
    Haddad SA; Palmer JR; Lunetta KL; Ng MC; ; Ruiz-Narváez EA
    PLoS One; 2017; 12(3):e0172577. PubMed ID: 28253288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single nucleotide polymorphisms of TCF7L2 are linked to diabetic coronary atherosclerosis.
    Muendlein A; Saely CH; Geller-Rhomberg S; Sonderegger G; Rein P; Winder T; Beer S; Vonbank A; Drexel H
    PLoS One; 2011 Mar; 6(3):e17978. PubMed ID: 21423583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stronger association of common variants in TCF7L2 gene with nonobese type 2 diabetes in the Latvian population.
    Kalnina I; Geldnere K; Tarasova L; Nikitina-Zake L; Peculis R; Fridmanis D; Pirags V; Klovins J
    Exp Clin Endocrinol Diabetes; 2012 Sep; 120(8):466-8. PubMed ID: 22441719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbean men and women.
    Humphries SE; Gable D; Cooper JA; Ireland H; Stephens JW; Hurel SJ; Li KW; Palmen J; Miller MA; Cappuccio FP; Elkeles R; Godsland I; Miller GJ; Talmud PJ
    J Mol Med (Berl); 2006 Dec; 84(12):1005-14. PubMed ID: 17665514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants of TCF7L2 gene and its coherence with metabolic parameters in Lithuanian (Kaunas district) women population with previously diagnosed gestational diabetes mellitus compared to general population.
    Francaite-Daugeliene M; Lesauskaite V; Tamosiunas A; Jasukaitiene A; Velickienė D
    Diabetes Res Clin Pract; 2021 Feb; 172():108636. PubMed ID: 33352264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of KCNJ1 variation with change in fasting glucose and new onset diabetes during HCTZ treatment.
    Karnes JH; McDonough CW; Gong Y; Vo TT; Langaee TY; Chapman AB; Gums JG; Beitelshees AL; Bailey KR; Del-Aguila JL; Boerwinkle EA; Pepine CJ; Turner ST; Johnson JA; Cooper-DeHoff RM
    Pharmacogenomics J; 2013 Oct; 13(5):430-6. PubMed ID: 22907731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics.
    McDonough CW; Burbage SE; Duarte JD; Gong Y; Langaee TY; Turner ST; Gums JG; Chapman AB; Bailey KR; Beitelshees AL; Boerwinkle E; Pepine CJ; Cooper-DeHoff RM; Johnson JA
    J Hypertens; 2013 Apr; 31(4):698-704. PubMed ID: 23353631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of LRP5, TCF7L2, and GCG variants and type 2 diabetes mellitus as well as fasting plasma glucose and lipid metabolism indexes.
    Wang J; Yan G; Zhang J; Gao K; Zhang M; Li L; Wang Y; Wang Q; Zhai Y; You H; Ren Y; Wang B; Hu D
    Hum Immunol; 2015 May; 76(5):339-43. PubMed ID: 25863010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCF7L2 gene polymorphisms and type 2 diabetes: association with diabetic retinopathy and cardiovascular autonomic neuropathy.
    Ciccacci C; Di Fusco D; Cacciotti L; Morganti R; D'Amato C; Novelli G; Sangiuolo F; Spallone V; Borgiani P
    Acta Diabetol; 2013 Oct; 50(5):789-99. PubMed ID: 22843023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.